We are live on ! Find out more
SEC

Seven Eight Capital Portfolio holdings

AUM $1.11B
1-Year Est. Return 29.48%
This Fund
S&P 500
This Quarter Est. Return
+14.58%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$865M
AUM Growth
+$9.54M
Cap. Flow
-$78.4M
Cap. Flow %
-9.07%
Top 10 Hldgs %
8.56%
Holding
892
New
315
Increased
150
Reduced
128
Closed
299

Top Buys

Rank Stock Value
1
XP icon
XP
XP
+$7.27M
2
STZ icon
Constellation Brands
STZ
+$7.01M
3
LLY icon
Eli Lilly
LLY
+$6.9M
4
ADP icon
Automatic Data Processing
ADP
+$6.79M
5
NU icon
Nu Holdings
NU
+$6.73M

Sector Composition

Rank Sector Weight
1 Technology 19.67%
2 Healthcare 18.49%
3 Consumer Discretionary 15.79%
4 Industrials 10.31%
5 Financials 10.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRN
876
DELISTED
Veren
VRN
-157,046
Closed -$1.3M
XYZ
877
Block Inc
XYZ
$48.8B
-103,381
Closed -$4.58M
SGI
878
Somnigroup International
SGI
$14B
-15,386
Closed -$667K
HCP
879
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
-13,816
Closed -$315K
SUM
880
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
-60,080
Closed -$1.87M
SMAR
881
DELISTED
Smartsheet Inc.
SMAR
-47,428
Closed -$1.92M
DO
882
DELISTED
Diamond Offshore Drilling, Inc.
DO
-56,073
Closed -$823K
MORF
883
DELISTED
Morphic Holding, Inc. Common Stock
MORF
-51,022
Closed -$1.17M
SPWR
884
DELISTED
SunPower Corporation Common Stock
SPWR
-296,468
Closed -$1.83M
PXD
885
DELISTED
Pioneer Natural Resource Co.
PXD
-13,936
Closed -$3.2M
CBAY
886
DELISTED
Cymabay Therapeutics
CBAY
-41,556
Closed -$620K
IMGN
887
DELISTED
Immunogen Inc
IMGN
-238,930
Closed -$3.79M
DEN
888
DELISTED
Denbury Inc.
DEN
-38,547
Closed -$3.78M
ARCH
889
DELISTED
Arch Resources, Inc.
ARCH
-2,732
Closed -$466K
ESTE
890
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
-87,051
Closed -$1.76M
DISH
891
DELISTED
DISH Network Corp.
DISH
-62,206
Closed -$365K
LAC
892
DELISTED
Lithium Americas Corp. Common Shares
LAC
-24,144
Closed -$411K

Similar funds

Seven Eight Capital's Q4 2023 Portfolio in Review

As of Q4 2023, Seven Eight Capital held 892 positions worth $865M, up 1.1% from $855M the previous quarter. Its ten largest holdings account for 8.6% of the portfolio.

Seven Eight Capital withdrew a net $78.4M in Q4 2023, closing 299 positions and reducing 128 holdings. Its most notable exit was Merck, an estimated $11.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Seven Eight Capital opened a new position in XP worth $8.3M.

  • Seven Eight Capital's largest Q4 2023 buy was XP: 318,542 shares worth $8.3M.
  • Seven Eight Capital added most to Constellation Brands in Q4 2023, an estimated $7.01M increase.
  • Seven Eight Capital's biggest Q4 2023 reduction was Vertex Pharmaceuticals, cutting an estimated $11.9M.
  • Seven Eight Capital fully exited Merck in Q4 2023, selling an estimated $11.9M.
  • Seven Eight Capital's ten largest holdings make up 8.6% of its $865M portfolio in Q4 2023.
  • Seven Eight Capital opened 315 new positions and closed 299 in Q4 2023.
  • Seven Eight Capital's portfolio value rose 1.1% quarter-over-quarter to $865M.

Based on Seven Eight Capital's 13F filing for Q4 2023, filed 13 Feb 2024.